Mindfulness and Migraine Research Study
Launched by CALIFORNIA PACIFIC MEDICAL CENTER RESEARCH INSTITUTE · Jul 1, 2016
Trial Information
Current as of July 06, 2025
Completed
Keywords
ClinConnect Summary
Migraine, one of the most common neurological disorders in the U.S., is ranked among the top 20 causes of disability worldwide. Migraine is currently one of the leading causes of disease burden for women aged 15-44 years and affects an estimated 11% of the adult population globally, with a strong female predominance. Current approaches to therapy are primarily medication-based but are limited by often-inadequate effectiveness, high costs for many migraine-specific medications, and common side effects. In addition, there likely exist subtypes of migraine that may affect the likelihood of res...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • 4-20 headaches per month (based on run-in headache diary)
- Exclusion Criteria:
- • No meditation or MBSR during the past 6 months
- • Cognitively or emotionally impaired as judged by a research physician prior to randomization
- • Pregnant
- • Lack of English language skills
- • No new migraine medication in past month
- • Incomplete headache diary during run-in period
About California Pacific Medical Center Research Institute
California Pacific Medical Center Research Institute is a leading clinical research organization affiliated with the California Pacific Medical Center in San Francisco. Focused on advancing medical knowledge and improving patient outcomes, the institute conducts innovative clinical trials across various therapeutic areas, including cardiology, oncology, and neurology. With a commitment to rigorous scientific standards and ethical research practices, the institute collaborates with academic institutions, industry partners, and healthcare providers to develop and evaluate new therapies and interventions, ultimately striving to translate research findings into effective clinical applications for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials